Notice of Annual General Meeting
Notice of Annual General Meeting
29 May 2026
ProBiotix Health plc (AQSE: PBX), the life sciences business developing probiotics to support cardiometabolic health, is pleased to announce that Notice convening the Company’s Annual General Meeting for 11:00 am on 23 June 2026 at the offices of AlbR Capital Limited, 3rd Floor 80 Cheapside, London EC2V 6EE. The accounts for the year to 31 December 2025, and the Notice of AGM will be available on the Company’s website at www.probiotixhealth-ir.com shortly
For further information, please contact:
|
ProBiotix Health plc |
https://probiotixhealth-ir.com/ |
|
Steen Andersen, Chief Executive Officer |
|
|
|
|
|
AlbR Capital Limited |
Tel: 020 7469 0930 |
|
David Coffman |
|
Notes to Editors:
ProBiotix Health is a life sciences company that develops probiotic formulations to support cardiometabolic health. Since its formation, ProBiotix has become recognised as a global leader in microbiome modulating probiotics for use in food supplements and nutraceuticals.
The Company has a unique approach; discovering ground breaking probiotics, ensuring their benefits through robust science, and bringing to market effective finished probiotic-based products for human health across the globe.